van Dongen GAMS - Search Results

1

The Role of ⁸⁹Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals.

van Dongen GAMS, Beaino W, Windhorst AD, Zwezerijnen GJC, Oprea-Lager DE, Hendrikse NH, van Kuijk C, Boellaard R, Huisman MC, Vugts DJ. van Dongen GAMS, et al. Among authors: van kuijk c. J Nucl Med. 2021 Apr;62(4):438-445. doi: 10.2967/jnumed.119.239558. Epub 2020 Dec 4. J Nucl Med. 2021. PMID: 33277395 Free article. Review.

2

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Aug;44(8):1271-81. J Nucl Med. 2003. PMID: 12902418 Free article.

3

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. Cancer Biother Radiopharm. 2003 Aug;18(4):655-61. doi: 10.1089/108497803322287745. Cancer Biother Radiopharm. 2003. PMID: 14503961

4

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

5

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.

Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O. Brouwers A, et al. Cancer Biother Radiopharm. 2004 Apr;19(2):155-63. doi: 10.1089/108497804323071922. Cancer Biother Radiopharm. 2004. PMID: 15186595 Free article.

6

High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.

Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. Verel I, et al. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1645-52. doi: 10.1007/s00259-004-1632-8. Epub 2004 Jul 31. Eur J Nucl Med Mol Imaging. 2004. PMID: 15290121

7

The promise of immuno-PET in radioimmunotherapy.

Verel I, Visser GW, van Dongen GA. Verel I, et al. J Nucl Med. 2005 Jan;46 Suppl 1:164S-71S. J Nucl Med. 2005. PMID: 15653665 Free article. Review.

8

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, van Dongen GA. Perk LR, et al. J Nucl Med. 2005 Nov;46(11):1898-906. J Nucl Med. 2005. PMID: 16269605 Free article.

9

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA. Börjesson PK, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2133-40. doi: 10.1158/1078-0432.CCR-05-2137. Clin Cancer Res. 2006. PMID: 16609026

10

Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.

Lubberink M, van Schie A, de Jong HW, van Dongen GA, Teule GJ. Lubberink M, et al. J Nucl Med. 2006 Aug;47(8):1375-81. J Nucl Med. 2006. PMID: 16883019 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters